Leerink Partners

A psychedelics-focused biopharmaceutical company Mind Medicine (MindMed) (NASDAQ:MNMD) announced Friday the pricing of an underwritten public offering of 9.29 million shares without par value, at a price of $7.00 per share. Through this round, the New York-headquartered company aims to raise $75...

A Supreme Court case tackling whether the federal government must reimburse health insurers that lost money participating in the Affordable Care Act is worth billions collectively and will be closely watched — but the outcome is unlikely to have a big impact on the insurers’ bottom...

The biotech firm Tocagen Inc. plans an Initial Public Offering to finance ongoing clinical trials of a technique that uses a weaponized virus to help the body’s immune system battle a common and deadly type of brain cancer. San Diego-based Tocagen has applied for a listing on the Nasdaq with...

After Fitbit Inc (NYSE: FIT)'s not-so-disappointing Q3 report but lowered guidance for Q4 and beyond, the market reacted. Shares were trading down nearly 30 percent mid-day Thursday with little or no bounce back after hitting $9 per share. Morgan Stanley Research: Downgraded to Equal Weight...

2016’s slow start for Initial Public Offerings (IPO) could be over, as four biotechs follow in the wake of several successful IPOs, most notably, BATS Global Markets, Inc. (BATS: BATS) and American Renal Associates Holdings Inc (NYSE: ARA). These stocks are up 25 and 26 percent, respectively...

SunGard's Astec Analytics looks into short-selling activity. This week’s top pick, from a securities lending perspective, is Amazon.com, Inc. (NASDAQ: AMZN). Other stocks that are seeing substantial short-selling activity include ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), Chesapeake Energy...

Teladoc Inc (NYSE: TDOC) shares are down 22 percent over the past month, declining steadily since August 10. Leerink Partners’ Steven Wardell initiated coverage of the company with an Outperform rating and a price target of $35. Telehealth has made an entry into the mainstream,...

Anthem Inc (NYSE: ANTM) announced on Friday that it will be buying competitor CIGNA Corporation (NYSE: CI) in a $54.2 billion cash and stock deal. Ana Gupte, Leerink Partners senior health care analyst, was on CNBC to discuss the deal and how it benefits both companies and their shareholders....

The health insurance industry seems to be in a takeover mania right now with all the major five players involved in one way or the other. While Aetna Inc (NYSE: AET) made an offer for Humana Inc (NYSE: HUM) recently, Anthem Inc (NYSE: ANTM) made a $184 per share takeover bid for CIGNA Corporation...

Wayne Farms Inc (NASDAQ: WNFM), the sixth largest producer and processor of broiler chickens, plans to raise over $300 million in its IPO this Thursday. The company is being spun off from parent Continental Grain. Wayne Farms expects to offer over 12.8 million shares between $18 and $21 per share...

Aetna Inc (NYSE: AET) came out with better-than-expected first-quarter results on Tuesday. Operating EPS for the company came at $2.39 on revenue of $51.1 billion, versus analysts' expectations of $1.95 and $15.5 billion respectively. Ana Gupte from Leerink Partners, was on CNBC following the...

Inotek Pharmaceuticals Corp (NASDAQ: ITEK), founded in 1999, is a clinical-stage biopharmaceutical company centered on the discovery, development and commercialization of therapies to treat glaucoma. Glaucoma is condition where the eye is unable to properly drain fluid, which leads to a buildup...